EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors

Pedro Eduardo Nascimento Silva Vasconcelos(Harvard University), Daniel B. Costa(Beth Israel Deaconess Medical Center)

JTO Clinical and Research Reports

May 13, 2020

10.1016/j.jtocrr.2020.100051

Cited by 81

Related Papers

CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib

|Journal of Clinical Oncology|2011|590

BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

|PLoS Medicine|2007|490

Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer

|Lung Cancer|2013|93

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors

|Lung Cancer|2023|6